Current and historical daily PE Ratio for Zhejiang Jiuzhou Pharmaceutical Co Ltd (
SHSE:603456
) from 2014 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zhejiang Jiuzhou Pharmaceutical stock (SHSE:603456) PE ratio as of Jun 05 2024 is 13.56.
More Details
Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) PE Ratio (TTM) Chart
Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Zhejiang Jiuzhou Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 13.6 | 2024-03-28 | 16.4 |
| 2024-06-04 | 13.6 | 2024-03-27 | 15.5 |
| 2024-06-03 | 13.4 | 2024-03-26 | 15.8 |
| 2024-05-31 | 13.7 | 2024-03-25 | 16.1 |
| 2024-05-30 | 13.8 | 2024-03-22 | 16.3 |
| 2024-05-29 | 13.7 | 2024-03-21 | 16.9 |
| 2024-05-28 | 13.7 | 2024-03-20 | 17.1 |
| 2024-05-27 | 13.9 | 2024-03-19 | 17.0 |
| 2024-05-24 | 13.8 | 2024-03-18 | 17.3 |
| 2024-05-23 | 14.1 | 2024-03-15 | 17.1 |
| 2024-05-22 | 14.5 | 2024-03-14 | 17.2 |
| 2024-05-21 | 14.5 | 2024-03-13 | 17.2 |
| 2024-05-20 | 14.7 | 2024-03-12 | 17.4 |
| 2024-05-17 | 14.5 | 2024-03-11 | 16.9 |
| 2024-05-16 | 14.4 | 2024-03-08 | 16.3 |
| 2024-05-15 | 14.4 | 2024-03-07 | 16.3 |
| 2024-05-14 | 14.7 | 2024-03-06 | 17.4 |
| 2024-05-13 | 14.7 | 2024-03-05 | 17.5 |
| 2024-05-10 | 14.9 | 2024-03-04 | 18.1 |
| 2024-05-09 | 15.1 | 2024-03-01 | 17.6 |
| 2024-05-08 | 14.9 | 2024-02-29 | 17.6 |
| 2024-05-07 | 15.0 | 2024-02-28 | 17.5 |
| 2024-05-06 | 15.1 | 2024-02-27 | 17.9 |
| 2024-04-30 | 14.7 | 2024-02-26 | 17.5 |
| 2024-04-29 | 14.7 | 2024-02-23 | 17.1 |
| 2024-04-26 | 14.2 | 2024-02-22 | 17.1 |
| 2024-04-25 | 13.7 | 2024-02-21 | 17.0 |
| 2024-04-24 | 13.4 | 2024-02-20 | 17.0 |
| 2024-04-23 | 13.6 | 2024-02-19 | 16.8 |
| 2024-04-22 | 13.5 | 2024-02-16 | 17.3 |
| 2024-04-19 | 13.4 | 2024-02-09 | 17.3 |
| 2024-04-18 | 13.8 | 2024-02-08 | 17.3 |
| 2024-04-17 | 14.0 | 2024-02-07 | 17.1 |
| 2024-04-16 | 13.6 | 2024-02-06 | 15.6 |
| 2024-04-15 | 14.0 | 2024-02-05 | 14.4 |
| 2024-04-12 | 14.3 | 2024-02-02 | 14.8 |
| 2024-04-11 | 14.4 | 2024-02-01 | 15.8 |
| 2024-04-10 | 14.9 | 2024-01-31 | 15.5 |
| 2024-04-09 | 15.1 | 2024-01-30 | 16.2 |
| 2024-04-08 | 15.5 | 2024-01-29 | 16.5 |
| 2024-04-05 | 16.3 | 2024-01-26 | 16.8 |
| 2024-04-03 | 16.3 | 2024-01-25 | 17.7 |
| 2024-04-02 | 16.3 | 2024-01-24 | 17.2 |
| 2024-04-01 | 16.5 | 2024-01-23 | 17.1 |
| 2024-03-29 | 16.2 | 2024-01-22 | 16.9 |
Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Zhejiang Jiuzhou Pharmaceutical Co Ltd
ISIN : CNE100001W36
Share Class Description:
SHSE:603456: Class ACompare
Compare
Traded in other countries / regions
603456.China IPO Date
2014-10-10Description
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers